SANDOZ LENALIDOMIDE

Sandoz Canada, Inc.🇨🇦 Health Canada

Approval Id: cecb00357d155bb1
Drug Approval Canada Name: SANDOZ LENALIDOMIDE
Product Name: SANDOZ LENALIDOMIDE
Status: Marketed
Status Date: 2021-09-07
Original Market Date: 2021-09-07
Din: 02518619
Drug Class: Human
Dosage Form: Capsule
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 10:00.00
Atc Original: L04AX04 LENALIDOMIDE
Atc Name: l 04 ax 04
Aig Number: 0152422004
Company Name: Sandoz Canada, Inc.
Company Address: 4600 Rue Armand-Frappier, Saint-Hubert, Quebec, Canada, J3Z 1G5
Company Detail Path: /organization/sandoz-canada-inc

LENALIDOMIDE

25 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

cecb00357d155bb1

Type

Standard